AAAAAA

   
Results: 1-16 |
Results: 16
Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: Case report and review of the literature
Authors: Bangalore, N Bhargava, P Hawkins, MJ Bhargava, P
Citation: N. Bangalore et al., Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: Case report and review of the literature, ANN ONCOL, 12(2), 2001, pp. 271-274
Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-alpha 2a) plus an anthracycline-based induction regimen
Authors: Smalley, RV Weller, E Hawkins, MJ Oken, MM O'Connell, MJ Haase-Statz, S Borden, EC
Citation: Rv. Smalley et al., Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-alpha 2a) plus an anthracycline-based induction regimen, LEUKEMIA, 15(7), 2001, pp. 1118-1122
Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin
Authors: Peck, RA Hewett, J Harding, MW Wang, YM Chaturvedi, PR Bhatnagar, A Ziessman, H Atkins, F Hawkins, MJ
Citation: Ra. Peck et al., Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin, J CL ONCOL, 19(12), 2001, pp. 3130-3141
Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer
Authors: Bhargava, P Marshall, JL Fried, K Williams, M Lefebvre, P Dahut, W Hanfelt, J Gehan, E Figuera, M Hawkins, MJ Rizvi, NA
Citation: P. Bhargava et al., Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer, CANC CHEMOT, 48(2), 2001, pp. 95-103
Risk factors for clinical salmonellosis in Virginia, USA cattle herds
Authors: Warnick, LD Crofton, LM Pelzer, KD Hawkins, MJ
Citation: Ld. Warnick et al., Risk factors for clinical salmonellosis in Virginia, USA cattle herds, PREV VET M, 49(3-4), 2001, pp. 259-275
Drilling-operations learning through visualization
Authors: Sanstrom, WC Hawkins, MJ
Citation: Wc. Sanstrom et Mj. Hawkins, Drilling-operations learning through visualization, J PETRO TEC, 53(1), 2001, pp. 28-29
A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors
Authors: Chen, HX Marshall, JL Ness, E Martin, RR Dvorchik, B Rizvi, N Marquis, J McKinlay, M Dahut, W Hawkins, MJ
Citation: Hx. Chen et al., A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors, CLIN CANC R, 6(4), 2000, pp. 1259-1266
Phase II evaluation of thalidomide in patients with metastatic breast cancer
Authors: Baidas, SM Winer, EP Fleming, GF Harris, L Pluda, JM Crawford, JG Yamauchi, H Isaacs, C Hanfelt, J Tefft, M Flockhart, D Johnson, MD Hawkins, MJ Lippman, ME Hayes, DF
Citation: Sm. Baidas et al., Phase II evaluation of thalidomide in patients with metastatic breast cancer, J CL ONCOL, 18(14), 2000, pp. 2710-2717
TNP-470
Authors: Bhargava, P Dordal, MS Hawkins, MJ
Citation: P. Bhargava et al., TNP-470, ANGIOGENESIS IN HEALTH AND DISEASE, 2000, pp. 387-406
A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies
Authors: Posey, JA Raspet, R Verma, U Deo, YM Keller, T Marshall, JL Hodgson, J Mazumder, A Hawkins, MJ
Citation: Ja. Posey et al., A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies, J IMMUNOTH, 22(4), 1999, pp. 371-379
A phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer
Authors: Bhargava, P Marshall, JL Rizvi, N Dahut, W Yoe, J Figuera, M Phipps, K Ong, VS Kato, A Hawkins, MJ
Citation: P. Bhargava et al., A phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer, CLIN CANC R, 5(8), 1999, pp. 1989-1995
A Phase I study of LGD1069 in adults with advanced cancer
Authors: Rizvi, NA Marshall, JL Dahut, W Ness, E Truglia, JA Loewen, G Gill, GM Ulm, EH Geiser, R Jaunakais, D Hawkins, MJ
Citation: Na. Rizvi et al., A Phase I study of LGD1069 in adults with advanced cancer, CLIN CANC R, 5(7), 1999, pp. 1658-1664
Heterocycle-peptide hybrid compounds. Aminotriazole-containing agonists ofthe thrombin receptor (PAR-1)
Authors: McComsey, DF Hawkins, MJ Andrade-Gordon, P Addo, MF Oksenberg, D Maryanoff, BE
Citation: Df. Mccomsey et al., Heterocycle-peptide hybrid compounds. Aminotriazole-containing agonists ofthe thrombin receptor (PAR-1), BIOORG MED, 9(10), 1999, pp. 1423-1428
Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen
Authors: Marshall, JL Hawkins, MJ Tsang, KY Richmond, E Pedicano, JE Zhu, MZ Schlom, J
Citation: Jl. Marshall et al., Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen, J CL ONCOL, 17(1), 1999, pp. 332-337
Docetaxel and gemcitabine combinations in non-small cell lung cancer
Authors: Rizvi, NA Spiridonidis, CH Davis, TH Bhargava, P Marshall, JL Dahut, W Figuera, M Hawkins, MJ
Citation: Na. Rizvi et al., Docetaxel and gemcitabine combinations in non-small cell lung cancer, SEMIN ONCOL, 26(5), 1999, pp. 27-31
Depressive symptomatology and specificity of social support
Authors: Hawkins, WE Tan, PP Hawkins, MJ Smith, E Ryan, E
Citation: We. Hawkins et al., Depressive symptomatology and specificity of social support, PSYCHOL REP, 84(3), 1999, pp. 1180-1186
Risultati: 1-16 |